Two chronic stress models based on movement restriction in rats respond selectively to antidepressant drugs: Aldolase C as a potential biomarker

International Journal of Neuropsychopharmacology

Volumn 18, Issue 10, 2015, Pages

  Ampuero, Estibaliz ^a,b   Luarte, Alejandro ^a   Santibañez, Marcos ^a   Varas Godoy, Manuel ^a,d   Toledo, Jorge ^a   Diaz Veliz, Gabriela ^c   Cavada, Gabriel ^a   Javier Rubio, F ^a   Wyneken, Ursula ^a  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chronic stress; Fluoxetine; Immobilization; Reboxetine; Restraint

Indexed keywords

ALDOLASE C; FLUOXETINE; FRUCTOSE BISPHOSPHATE ALDOLASE; REBOXETINE; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; GREEN FLUORESCENT PROTEIN; MORPHOLINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANHEDONIA; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CEREBROSPINAL FLUID; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; ELEVATED PLUS MAZE TEST; FEEDING BEHAVIOR; FORCED SWIM TEST; FOREBRAIN; IMMOBILITY; IMMOBILIZATION STRESS; LEARNED HELPLESSNESS; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SUCROSE PREFERENCE TEST; TAIL SUSPENSION TEST; TREATMENT OUTCOME; UPREGULATION; ANIMAL; CHRONIC DISEASE; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DISEASE MODEL; EXERCISE; MENTAL STRESS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FLUOXETINE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GREEN FLUORESCENT PROTEINS; MALE; MORPHOLINES; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL;

EID: 84957817888     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv038     Document Type: Article

References (45)

1. Ampuero E, Rubio FJ, Falcon R, Sandoval M, Diaz-Veliz G, Gonzalez RE, Earle N, Dagnino-Subiabre A, Aboitiz F, Orrego F, Wyneken U (2010) Chronic fuoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neuroscience 169:98-108.
2. Ampuero E, Stehberg J, Gonzalez D, Besser N, Ferrero M, Diaz-Veliz G, Wyneken U, Rubio FJ (2013) Repetitive fuoxetine treatment affects long-term memories but not learning. Behav Brain Res 247:92-100.
3. Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ, Radulovic J, Churchill GA, Redei EE (2012) Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry 17:49-61.
4. Babenko O, Golubov A, Ilnytskyy Y, Kovalchuk I, Metz GA (2012) Genomic and epigenomic responses to chronic stress involve miRNA-mediated programming. PLoS One 7:e29441.
5. Belzung C (2014) Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects? Neuropsychopharmacology 39:1041-1051.
6. Booth FW, Roberts CK, Laye MJ (2012) Lack of exercise is a major cause of chronic diseases. Comprehens Physiol 2:1143-1211.
7. Bradley AJ, Lenox-Smith AJ (2013) Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve effcacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. J Psychopharmacol 27:740-758.
8. Brown WA (2007) Treatment response in melancholia. Acta psy-chiatrica Scandinavica Supplementum:125-129.
9. Buynitsky T, Mostofsky DI (2009) Restraint stress in biobehav-ioral research: Recent developments. Neurosci Biobehav Rev 33:1089-1098.
10. Canete-Soler R, Reddy KS, Tolan DR, Zhai J (2005) Aldolases a and C are ribonucleolytic components of a neuronal complex that regulates the stability of the light-neuroflament mRNA. J Neurosci 25:4353-4364.
11. Chen F, LoTurco J (2012) A method for stable transgenesis of radial glia lineage in rat neocortex by piggyBac mediated transposition. J Neurosci Methods 207:172-180.
12. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245.
13. Czeh B, Muller-Keuker JI, Rygula R, Abumaria N, Hiemke C, Domenici E, Fuchs E (2007) Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fuoxetine treatment. Neuropsychopharmacology 32:1490-1503.
14. Dringenberg HC, Branfeld Day LR, Choi DH (2014) Chronic fuox-etine treatment suppresses plasticity (long-term potentia-tion) in the mature rodent primary auditory cortex in vivo. Neur Plasticity 2014:571285.
15. Dwivedi Y (2014) Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues Clin Neurosci 16:43-61.
16. Feder A, Nestler EJ, Charney DS (2009) Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 10:446-457.
17. Flint J, Kendler KS (2014) The genetics of major depression. Neuron 81:484-503.
18. Guirado R, Perez-Rando M, Sanchez-Matarredona D, Castren E, Nacher J (2014) Chronic fuoxetine treatment alters the structure, connectivity and plasticity of cortical interneurons. Int J Neuropsychopharmacol 17:1635-1646.
19. Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF (2002) Patterns and predictors of remission, response and recovery in major depression treated with fuoxetine or nortriptyline. Aus New Zeal J Psychiatry 36:384-391.
20. Kalueff AV, Tuohimaa P (2005) Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAe-rgic drugs. Eur J Pharmacol 508:147-153.
21. Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD (2010) Biomarkers to predict antide-pressant response. Curr Psychiatry Rep 12:553-562.
22. Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434-445.
23. Magarinos AM, McEwen BS (1995) Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 69:83-88.
24. Meerson A, Cacheaux L, Goosens KA, Sapolsky RM, Soreq H, Kaufer D (2010) Changes in brain MicroRNAs contribute to cholinergic stress reactions. J Molec Neurosci 40:47-55.
25. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161-1169.
26. Papakostas GI, Fava M (2005) Monoamine-based pharmacother-apy. In: Biology of depression: from novel insights to therapeutic strategies. 1st ed. (M LJW, ed), pp 87-140. Weinheim, Germany:.
27. Papakostas GI, Fava M, Thase ME (2008a) Treatment of SSRI-resistant depression: a meta-analysis comparing within-versus across-class switches. Biol Psychiatry 63:699-704.
28. Papakostas GI, Nelson JC, Kasper S, Moller HJ (2008b) A meta-analysis of clinical trials comparing reboxetine, a nor-epinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Neuropsychopharmacol 18:122-127.
29. Pastor-Ciurana J, Rabasa C, Ortega-Sanchez JA, Sanchis-Olle M, Gabriel-Salazar M, Ginesta M, Belda X, Daviu N, Nadal R, Armario A (2014) Prior exposure to repeated immobilization or chronic unpredictable stress protects from some negative sequels of an acute immobilization. Behav Brain Res 265:155-162.
30. Perry PJ (1996) Pharmacotherapy for major depression with melancholic features: relative effcacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 39:1-6.
31. Peselow ED, Sanflipo MP, Difglia C, Fieve RR (1992) Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 149:1324-1334.
32. Ramirez G, Toro R, Dobeli H, von Bernhardi R (2005) Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-infammatory molecules is mediated by astrocytes. Neu-robiol Dis 19:243-254.
33. Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P, Domenici E, Chao MV, Mannisto PT, Castren E (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32:2152-2162.
34. Rinaldi A, Vincenti S, De Vito F, Bozzoni I, Oliverio A, Presutti C, Fragapane P, Mele A (2010) Stress induces region specifc alterations in microRNAs expression in mice. Behav Brain Res 208:265-269.
35. Rosen GD, Bai J, Wang Y, Fiondella CG, Threlkeld SW, LoTurco JJ, Galaburda AM (2007) Disruption of neuronal migration by RNAi of Dyx1c1 results in neocortical and hippocampal malformations. Cereb Cortex 17:2562-2572.
36. Rubio FJ, Ampuero E, Sandoval R, Toledo J, Pancetti F, Wyneken U (2013) Long-term fuoxetine treatment induces input-specifc LTP and LTD impairment and structural plasticity in the CA1 hippocampal subfeld. Front Cell Neurosci 7:66.
37. Sandoval M, Luarte A, Herrera-Molina R, Varas-Godoy M, Santi-banez M, Rubio FJ, Smit AB, Gundelfnger ED, Li KW, Smalla KH, Wyneken U (2013) The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fuid after repetitive fuoxetine treatment. Brain Res 1520:1-14.
38. Shishkina GT, Kalinina TS, Dygalo NN (2007) Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fuoxetine treatment correlates with its antidepressant effect. Neuroscience 150:404-412.
39. Stewart JW, Garfnkel R, Nunes EV, Donovan S, Klein DF (1998) Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 18:429-434.
40. Toups M, Trivedi MH (2012) Biomarkers and the future of treatment for depression. Cerebrum: the Dana forum on brain science 2012:6.
41. Tzanakaki M, Guazzelli M, Nimatoudis I, Zissis NP, Smeraldi E, Rizzo F (2000) Increased remission rates with venlafax-ine compared with fuoxetine in hospitalized patients with major depression and melancholia. Int Clin Psychopharma-col 15:29-34.
42. Vialou V, Feng J, Robison AJ, Nestler EJ (2013) Epigenetic mechanisms of depression and antidepressant action. Annu Review Pharmacol Toxicol 53:59-87.
43. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neu-rosci 22:6810-6818.
44. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93:358-364.
45. Wyneken U, Sandoval M, Sandoval S, Jorquera F, Gonzalez I, Vargas F, Falcon R, Monari M, Orrego F (2006) Clinically relevant doses of fuoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Neuropsychop-harmacology 31:2415-2423.